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ABSTRACT
Objectives To study possible effects of aerosol exposure
on lung function, fractional exhaled nitric oxide (FeNO)
and inﬂammatory markers in blood from Norwegian
cement production workers across one work shift (0 to
8 h) and again 32 h after the non-exposed baseline
registration.
Methods 95 workers from two cement plants in
Norway were included. Assessment of lung function
included spirometry and gas diffusion pre- and post-shift
(0 and 8 h). FeNO concentrations were measured and
blood samples collected at 0, 8 and 32 h. Blood analysis
included cell counts of leucocytes and mediators of
inﬂammation.
Results The median respirable aerosol level was
0.3 mg/m
3 (range 0.02e6.2 mg/m
3). FEV1, FEF25e75%
and DLCO decreased by 37 ml (p¼0.04), 170 ml/s
(p<0.001) and 0.17 mmol/min/kPa (p¼0.02),
respectively, across the shift. A 2 ppm reduction in FeNO
between 0 and 32 h was detected (p¼0.01). The
number of leucocytes increased by 0.6310
9 cells/l
(p<0.001) across the shift, while ﬁbrinogen
levels increased by 0.02 g/l (p<0.001) from 0 to 32 h.
TNF-a level increased and IL-10 decreased across the
shift. Baseline levels of ﬁbrinogen were associated with
the highest level of respirable dust, and increased by
0.39 g/l (95% CI 0.06 to 0.72).
Conclusions We observed small cross-shift changes in
lung function and inﬂammatory markers among cement
production workers, indicating that inﬂammatory effects
may occur at exposure levels well below 1 mg/m
3.
However, because the associations between these acute
changes and personal exposure measurements were
weak and as the long-term consequences are unknown,
these ﬁndings should be tested in a follow-up study.
INTRODUCTION
The raw materials needed for the production of
cement are mainly limestone and sources of silica,
aluminium and iron. These are quarried, crushed
and milled to a raw meal, which is heated in a kiln
to approximately 14508C to form clinker (cement
base). The clinker is milled together with calcium
sulphate and other additives to produce cement of
different qualities.
A substantial number of cross-sectional studies
have found associations between aerosol exposure
and adverse respiratory health effects in cement
production workers.
1e7 However, other studies do
not show such associations.
89Most studies have
limitations because of their cross-sectional design,
selection bias and sparse quantitative exposure data.
In addition to the cross-sectional studies, there
are two cross-shift studies that show acute effects
among cement production workers. Reductions in
forced expiratory volume in 1 s (FEV1), FEV1/forced
vital capacity (FVC) and forced mid-expiratory
ﬂow rate (FEF)25e75% across a shift were observed
among Saudi Arabian workers
10 and a cross-shift
decrease in peak expiratory ﬂow (PEF) was
demonstrated in a Tanzanian study.
11 Both studies
were conducted in workers exposed to respirable
aerosol levels of between 7 and 15 mg/m
3, which
are well above the present occupational exposure
limit (OEL) of 5 mg/m
3 in most European coun-
tries. Hence, they do not provide information about
health effects at lower levels of exposure.
Few studies have attempted to elucidate the
underlying physiological mechanisms involved in
cement-induced respiratory effects. Irritation of
mucus membranes because of the alkaline proper-
ties of cement dust (wet cement has a pH of about
12) and the possibility that other content particles
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What this paper adds
< There are no former studies of gas diffusion
capacity, fractional exhaled nitric oxide (FeNO)
or inﬂammatory markers in blood among cement
production workers.
< We observed a cross-shift reduction in forced
expiratory volume in 1 s (FEV1), forced mid-
expiratory ﬂow rate (FEF)25e75% and FeNO
levels and an increase in white blood cells and
ﬁbrinogen levels, together with augmented
TNF-a and decreased IL-10 concentrations in
low level-exposed cement production workers.
< Because the correlations with personal expo-
sure measurements were weak and as the long-
term consequences of these acute changes in
lung function indices and inﬂammatory media-
tors are unknown, the hypothesis that low-level
cement aerosol exposure causes airway disease
should be tested in a follow-up study.
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Workplace(quartz, chromium) cause inﬂammation have been suggested. In
a recent experimental study, cement dust was found to activate
macrophage tumour necrosis factor (TNF)-a production in rat
alveolar macrophages.
12 We have previously observed an increase
in the proportion of neutrophils and levels of interleukin (IL)-1b
in induced sputum samples from cement production workers.
13
However, information on the effects of assessed exposure on gas
diffusion capacity (DLCO), fractional exhaled nitric oxide
(FeNO) or inﬂammatory markers in blood is lacking.
To study further the acute effects associated with cement dust
exposure, we aimed to investigate possible cross-shift changes in
lung function variables, FeNO and inﬂammatory markers in
peripheral blood. Personal aerosol levels were obtained in order to
analyse associations between exposure and effect.
MATERIALS AND METHODS
Design
Workers from two cement production plants in Norway were
examined before and after a shift of exposed work during the
winters of 2008 and 2009. At baseline, each worker was
required to have been off work for at least 2 days. The workers
were exposed to cement production dust between 0 and 8 h,
and again between 24 and 32 h. The participants underwent
spirometry, gas diffusion assessment, FeNO measurement and
blood sampling at baseline (0 h) and after a work shift (8 h). In
addition, a third examination was performed consisting of
FeNO measurements and blood sampling 32 h after baseline in
order to study possible delayed effects. Only non-smokers
(deﬁned as never-smokers or ex-smokers who had stopped
smoking at least 1 year before the examination) underwent
FeNO sampling.
After completion of the health examinations at baseline, each
worker was given a back-pack containing equipment for
personal exposure measurements. The sampling cassettes
collected respirable, thoracic and inhalable aerosol fractions and
were mounted on shoulder straps as close to the mouth as
possible. To minimise bias caused by their position, samplers
were carried in front of either the right or the left shoulder in
a random pattern. At the end of the shift, the equipment was
removed and a questionnaire on work tasks performed was
completed before the workers underwent the second health
examination. In this study, it was not feasible to collect aerosol
measurements on the second day (between 24 and 32 h).
Subjects
Exposed workers from the production and maintenance
departments were identiﬁed from the company’s register and
invited to participate in the study. The eligible workers
comprising of 144 subjects (5% females) were offered appoint-
ments for health examinations and exposure measurements. Of
the 124 workers present on examination days, 95 (7% females)
were willing to participate and were included in the study. The
participation rate was 66%. A ﬂowchart showing the inclusion
and exclusion of workers is presented in ﬁgure 1 and the popu-
lation characteristics are given in table 1.
The eligible workers received verbal and written information
and informed consent was obtained from all participating
subjects.
All included workers completed the investigation at baseline
and at 8 h, but two workers did not attend for the third inves-
tigation (32 h). Spirometry was performed for all workers, but
because of technical problems, the spirometry or gas diffusion
tests could not be performed for three of the workers at 8 h. One
worker did not meet the American Thoracic Society/European
Respiratory Society (ATS/ERS) criteria for spirometry or gas
diffusion
14 15 and was excluded from the cross-shift analysis of
lung function tests. Blood samples were not obtained on every
occasion from eight subjects and for one subject we did not
obtain any blood sample. The workers were asked: ‘Was your
allergy conﬁrmed by a physician?’ and ‘Was your asthma
conﬁrmed by a physician?’ If the answer was positive to either
of these questions, they were deﬁned as having doctor-diagnosed
allergy or asthma.
Of the workers who did not want to participate in the study,
two subjects had a known diagnosis of chronic obstructive
pulmonary disease (COPD) and one of asthma. In the same
group, eight workers had administrative jobs and were expected
to have very low exposure or not to be exposed at all. Fourteen
of the non-participants were non-smokers and 12 were smokers
at the time of the measurements. We had no information on the
smoking habits of three non-participating workers, but the
smokers tended to be more heavily exposed to tobacco smoke
than those included in the study.
Exposure assessment
The production of cement generates aerosols by mechanical and
condensation processes and particle size ranges from ultra ﬁne to
above the inhalable. The workers in both departments reported
day-to-day variation in work tasks and perceived exposure and
that the use of respiratory equipment varied between individuals
Figure 1 Flowchart for the inclusion and exclusion of cement
production workers. *Lung function testing. **Workers who did not
wish to participate 32 h after baseline.
Table 1 Population characteristics given as mean (SD),
duration of exposure and smoking status of cement
production workers
n9 5
Age, years 41 (13)
Height, cm 179 (7)
Body mass index 28 (4)
Duration of cement aerosol
exposure, years
16 (13)
Smoking status (%)
Never-smokers 36
Ex-smokers 23
Smokers* 41
*Including current smokers (n¼37) and ex-smokers who stopped less
than 1 year before the examinations (n¼2).
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Workplaceand tasks. Hence, the use of respirators was registered in order to
allow comparison of outcomes between those who used
a respirator and those who did not. The workers had access to
Airstream-, P2- and P3-respirators, but we did not have infor-
mation on which of these respirators the workers selected during
this particular shift. The workers used respirators made by
different manufacturers. The exposure measurements were
performed outside the respirators.
The inhalable aerosol fraction that contains particles that
enter the nose and mouth (<100 mm aerodynamic diameter, dae)
was collected with the IOM inhalable dust sampler (SCK,
Blandford Forum, Dorset, UK) equipped with a 25 mm cellulose-
ester membrane ﬁlter with pore size 5 mm (SMWP02500; Milli-
pore, Billerica, Massachusetts, USA) at a ﬂow rate of 2.0 l/min.
The thoracic fraction contains particles that pass the larynx
(50% cut-off at dae¼10 mm) and was collected with the BGI GK
2.69 respirable/thoracic sampler (BGI, Waltham, Massachusetts,
USA) with 37 mm polyvinyl chloride ﬁlters with pore size 5 mm
(Millipore, SKC and Pall, Port Washington, New York, USA) at
a ﬂow rate of 1.6 l/min.
The respirable fraction (50% cut-off at dae¼4 mm) that enters
the alveoli
16 was collected by the respirable cyclone (Cassella,
Amherst, New Hampshire, USA) with 37 mm polyvinyl chloride
ﬁlters with pore size 5 mma taﬂow rate of 2.2 l/min.
Lung function tests
Lung function tests were performed in accordance with ATS/
ERS guidelines
14 15 using the Jaeger Master Screen PFT (Erich
Jaeger, Würzburg, Germany). The same investigator (AKMF)
performed all lung function measurements. The workers were
given standard instructions on the forced maximal expiratory
manoeuvres and the transfer factor for the carbon monoxide
(DLCO) test, with demonstration of the procedures. The tests
were performed with the subject seated and breathing through
the mouthpiece with a nose clip. The spirometer was calibrated
with a 3 l syringe and test gas calibrations were performed using
the instrument’s automatic calibration programme. Both cali-
brations were performed daily. The best result, according to
ATS/ERS criteria, of at least three manoeuvres of ﬂow-volume
measurements was used in the analysis. FVC, FEV1, FEF25e75%
and forced expiratory ﬂow rates at 25%, 50% and 75% of FVC
expired (FEF25%, FEF50%, FEF75%) and PEF were measured.
Two measurements of DLCO were taken on each occasion and
the average of the two results was used in the analysis. Effective
alveolar volume was measured simultaneously by helium dilu-
tion and the gas transfer per unit effective alveolar volume (KCO)
was calculated. The lung function measurements were
performed before and after the work shift. Age, height, smoking
habits and weight were registered. Lung function testing was
performed subsequent to the exposure assessments, blood
sampling and FeNO measurements to allow adjustment to
indoor temperatures.
Fractional exhaled nitric oxide
FeNO in exhaled air was measured according to the ATS/ERS
criteria
17 using the NIOX MINO (Aerocrine, Solna, Sweden).
This device provides FeNO measurements at 50 ml/s exhalation
ﬂow rate, expressed in parts per billion (ppb) using an electro-
chemical sensor. The accuracy range of the NIOX MINO device
is 63 ppb for measured values <30 ppb and 10% of the
measured value for values >30 ppb, expressed as the standard
deviation of 10 consecutive measurements. The measurements
were performed before and after the work shift and again 32 h
after baseline. Subjects were advised not to consume food or
beverages 1 h before the measurements. Only non-smokers were
selected for FeNO testing and the measurements were
performed before the lung function measurements.
Assessment of blood parameters
Blood samples were collected at 0, 8 and 32 h in vacuum tubes
containing citrate or EDTA as anticoagulant or containing no
additives (serum). The citrate and serum tubes were centrifuged
at 14003g for 10 min. Plasma or serum was then aspirated and
aliquoted into 1.5 ml Eppendorf polypropylene cryotubes within
1 h. The plasma and serum tubes were stored at e808C until
analysed. Leucocytes were analysed in EDTA blood samples
within 48 h (in accordance with the instructions of the labora-
tory) using the Sysmex haematology system (Sysmex Europe,
Hamburg, Germany) at the Oslo University Hospital, Ullevål,
Oslo, Norway. The time period between the collection of blood
samples and analysis at the laboratory was approximately the
same for the two plants as transportation times were similar.
Quantitation of human serum C reactive protein (hsCRP) was
performed using a high sensitive (hs) immunoturbidimetric
assay on an Hitachi 917 Automatic Analyzer (Roche Diagnos-
tics, Mannheim, Germany). The inter-assay variation (coefﬁ-
cient of variation, CV) was 5%. The ﬁbrinogen concentration in
citrate plasma samples was analysed using a clotting test on the
STA-R Evolution (Diagnostica Stago, Asnières-sur-Seine, France).
The inter-assay variation (CV) was 4%. D-dimer citrate plasma
samples were analysed using an immunoturbidimetric method
on the STA-R Evolution. The inter-assay variation (CV) was 3%.
The serum samples were analysed for cytokines using
a microsphere-based multiplexing bioassay system with Xmap
technology (Luminex, Austin, Texas, USA). TNF-a, IL-1b, IL-6, IL-
8 and IL-10 were analysed using the Bio-Plex Human Group 1
assay 6-plex (Bio-Rad, Hercules, California, USA). Analysis was
performed according to the instructions of the manufacturer. The
inter-assay variations (CV %) were calculated from supernatant
aliquots (n¼8) of LPS exposed human monocytes, stored at
 808C: TNF-a 12%, IL-1b 8%, IL-6 12%, IL-8 16% and IL-10 15%.
The detection limits were set as the lowest standard in each
assay: TNF-a 0.16 pg/ml, IL-1b 0.06 pg/ml, IL-6 0.18 pg/ml, IL-8
0.04 pg/ml and IL-10 0.16 pg/ml.
Statistical methods
The Student paired t test was used to compare normally
distributed continuous outcomes (the cross-shift changes in lung
function indices). The Wilcoxon signed-rank test was used to
compare the FeNO and inﬂammatory markers cross-shift. The
Spearman rank test was used for correlations.
Independent variables considered to be biological important
cofactors were included in the linear regression models. In
addition, we included job task and location (plant 1 and 2) based
on assumptions of differences in exposure levels. The cross-shift
difference and the pre-shift level (8 h) of the health outcomes
were analysed as dependent variables. Sex, age, height, body
mass index, location (plant 1 or 2), report of doctor-diagnosed
asthma, upper respiratory infection during the preceding
3 weeks, work tasks, life dose of tobacco (in kg), as well as the
tertiles of the exposure levels (low, medium and high level as
dummy variables compared to the lowest level) were included as
independent variables for the lung function analysis. For the
inﬂammatory markers, the above-mentioned independent vari-
ables, except for height and report of doctor-diagnosed asthma,
were used in the regression model. Skewed variables were log-
transformed in order to obtain acceptable linear regression
models.
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WorkplaceThe study was designed with a power of 80% to detect a true
difference of 1.5% between FEV1/FVC measured at two time
points and a change in cytokine levels of 0.8 ng/l at a 5%
signiﬁcance level. At least 90 subjects were needed. Statistical
analysis was performed using SPSS v 15.0 (SPSS).
RESULTS
Exposure
Production workers performed inspection rounds throughout
the plant, participated in solving problems which occurred
during production (such as cleaning dust spills, carrying out
minor mechanical work and opening up clogged production
equipment) and also performed tasks in the control room. The
maintenance workers maintained production equipment
throughout the plant and inside their workshops. Respirable,
thoracic and inhalable aerosol fraction measurements from the
two cement producing plants are presented in table 2.
Six inhalable, four thoracic and eight respirable samplers did
not obtain valid aerosol measurements; the most important
reason was pump failure. The missing values were substituted
with values predicted by linear regression models of the three
aerosol fractions using the others as independent variables. The
regression equation for the thoracic fraction was: log(thoracic
value)¼0.291+1.01 log(respirable value) 0.12(factor for plant
1). For the inhalable fraction: log(inhalable value)¼0.82+0.96
log(thoracic value) and for the respirable fraction: log(respirable
value)¼ 0.32+0.79 log(thoracic value). The variance explained
by the regression models was 77e83%. The aerosol weight of
samples was corrected with ﬁeld blanks that had been weighed
on the same day. When the weight was below the detection
limit, the actual observed weight was used in the data analysis,
and values of 0 or less were replaced by the lowest observed
positive value within the job group divided by 2. Two of the
samples were below the results of the ﬁeld blanks.
The thoracic aerosol fraction was signiﬁcantly higher in plant
2 than in plant 1, whereas there was no difference in the
inhalable or respiratory fractions. In plant 1, 54% of the workers
had been using respirators, while 23% had done so in plant 2. Of
the 34 workers reporting use of respirators, 13 reported occa-
sional use, 12 reported use most of the time and 9 reported use
all the time. The aerosol concentrations were higher for those
using respirators (table 2). The median respirable aerosol as
a fraction of the inhalable aerosol was 10% and 8%, respectively,
for plants 1 and 2. The thoracic aerosol as a fraction of the
inhalable aerosol was 15% for plant 1 and 18% for plant 2.
Health effects
Lung function
We detected a decrease of 37 ml (p¼0.04) and 170 ml/s
(p<0.001), respectively, in FEV1 and FEF25e75% during the shift.
There was a decrease in the gas diffusion capacity of 0.17 mmol/
min/kPa (p¼0.02) across the shift. Selected lung function and
gas diffusion indices are presented in table 3.
No associations between the changes in lung function vari-
ables and exposure were observed. This was the case for the
whole group of workers and also when those who did not use
respiratory protection were analysed separately.
FeNO and blood parameters
There was a decrease of 2 ppm (p¼0.008) in FeNO between
baseline values and those at 32 h after baseline. Furthermore,
a signiﬁcant cross-shift increase in white blood cells of
0.6310
9 cells/l (p<0.001) was detected, while ﬁbrinogen levels
increased by 0.02 g/l (p<0.001) from baseline to 32 h. The
TNF-a level increased, whereas IL-10 decreased across the shift.
Thereafter, there was a decrease in all inﬂammatory markers
except IL-10. The levels of inﬂammatory markers and FeNO at 0,
8 and 32 h are shown in table 4.
The pattern of changes in inﬂammatory markers remained
unchanged when those without doctor-diagnosed allergy or
asthma were analysed separately. This was also the case for
non-smokers.
There was a positive correlation between the differences (0 to
32 h) in ﬁbrinogen and hsCRP (r¼0.48; p<0.001). In a multiple
linear regression model, the 0 h level of ﬁbrinogen was associated
with the highest respirable aerosol level (>0.4 mg/m
3), and
increased by 0.39 g/l (95% CI 0.06 to 0.72). There were no
associations between the cross-shift changes of the inﬂamma-
tory markers and the exposure variables for either the whole
group of workers or when stratiﬁed for the variable regarding use
of respiratory protection.
DISCUSSION
We observed a cross-shift reduction in FEV1, FEF25e75%,D L CO
and FeNO levels, and an increase in white blood cells and
ﬁbrinogen levels, together with elevated TNF-a levels and
Table 2 Exposure measurements by job category, and the values for workers using respirators compared to those without respirators
n
Inhalable aerosol Thoracic aerosol Respirable aerosol
AM GM GSD AM GM GSD AM GM GSD
Job category
Production 37 5.2 2.3 4.5 0.65 0.32 3.6 0.37 0.20 3.4
Electrical maintenance 9 5.5 2.7 3.6 0.59 0.37 2.7 0.24 0.19 2.2
Mechanical maintenance 27 7.7 3.5 4.0 1.2 0.59 3.2 0.73 0.33 3.5
Laboratory 3 0.91 0.65 3.2 0.20 0.14 3.3 0.11 0.10 2.0
Other 19 7.8 4.0 4.3 1.1 0.52 4.2 0.46 0.31 2.6
Total 95 6.3 2.8 4.3 0.88 0.42 3.6 0.47 0.24 3.2
Plant 1 39 5.2 2.5 3.8 0.62 0.30 3.5 0.36 0.21 3.0
Without respirator 18 1.4 0.90 2.8 0.16 0.11 2.4 0.13 0.088 2.3
With respirator 21 8.4 6.2z 2.2 1.1 0.73z 2.1 0.56 0.46z 1.9
Plant 2 56 7.1 3.0 4.7 1.1 0.52* 3.5 0.55 0.27 3.2
Without respirator 43 4.6 2.5 3.7 0.60 0.40 2.8 0.32 0.21 2.5
With respirator 13 15 5.6 8.0 2.5 1.3y 4.4 1.3 0.58y 4.8
*Signiﬁcantly different from plant 1, p¼0.04.
ySigniﬁcantly different from the category above, p<0.05.
zp<0.001.
AM, arithmetic mean; GM, geometric mean; GSD, geometric standard deviation.
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Workplacedecreased IL-10 in low level-exposed cement production workers.
No positive correlations between the cross-shift changes in lung
function, FeNO or inﬂammatory markers and the measurements
of personal exposure levels were detected.
Our ﬁnding of a cross-shift decrease in lung function indices
agrees with the results of two earlier cross-shift studies among
cement production workers exposed to higher levels of dust,
which showed a reduction in FEV1, FEV1/FVC, FEF25e75% and/
or PEF.
10 11 Cross-shift studies are of particular interest because
in occupationally exposed groups, a longitudinal decrease in lung
function seems to be associated with a cross-shift reduction in
these values.
18 19 We did not detect an association between the
changes in spirometric indices and individual exposures
measured in this study. Nevertheless, because diurnal variation
in spirometry in healthy, non-exposed subjects is shown to cause
an increase during the ﬁrst 6e8 h of time awake,
20 the observed
reduction in spirometric indices could possibly be associated
with job tasks, peak exposure or other unknown conditions not
measured in our study.
A cross-shift reduction in the gas diffusion capacity (assessed
as DLCO and KCO) was observed. There are no prior studies on
gas diffusion capacity among workers in this industry, but
reduced gas diffusion capacity has been shown in other indus-
tries with dusty environments.
21 A possible mechanism of
a decrease in DLCO could be that a fraction of the aerosol small
enough to reach the alveoli interacts with the alveolocapillary
function and thereby reduces gas diffusion capacity. Another
possibility is that exposures other than cement production dust,
such as inhalation of carbon monoxide from vehicles or
machines, could blockade the haemoglobin molecules and
thereby lower the gas diffusion capacity. However, this will
remain speculation until other studies on gas diffusion capacity
have been reported among these workers.
The changes in lung function were not accompanied by cross-
shift changes in FeNO levels, but a small signiﬁcant decrease was
observed when baseline values were compared with those
measured at 32 h. Reduced FeNO levels are observed in
smokers.
22 23 Our ﬁnding could possibly indicate a similar
response, but because the observed changes are minor and
because we did not have measurements at 24 h, this ﬁnding
needs to be conﬁrmed by others.
There was an increase in the number of leucocytes across the
shift. In light of this observation, it might be that cement dust
causes an increase in neutrophil activity. This would be in
agreement with our previous ﬁndings of an increased proportion
of neutrophils and levels of IL-1b in induced sputum from these
workers.
13
It has been shown that inhalation of very ﬁne dust from air
pollution and from occupational exposures can induce the
release of mediators that may inﬂuence blood coagulation.
24e28
Thus, the observed increase in ﬁbrinogen and hsCRP levels at
32 h accompanied by a positive correlation between the
Table 4 Blood parameters and FeNO levels pre-and post-shift (0 and 8 h) and at 32 h
Parameter n 0 h, median (range) n 8 h, median (range) n 32 h, median (range)
FeNO (ppb) 58 14 (0e96) 58 14 (0e98) 55 12 (0e82)z
Leucocytes (10
9/l) 86 7.4 (4.8e13.5) 86 8.0 (4.8e13.6)y 83 7.2 (4.3e14.3)y
CRP (ng/l) 93 1.58 (0.26e16.38) 93 1.53 (0.19e12.79) 90 1.87 (0.27e18.94)*
Fibrinogen (g/l) 86 3.09 (1.68e5.13) ee 86 3.11 (2.26e5.08)y
D-dimer (ng/l) 86 0.29 (0.22e1.04) ee 86 0.29 (0.22e1.04)
IL-1b (ng/l) 88 0.25 (0.09e7.00) 88 0.23 (0.09e3.51) 88 0.20 (0.09e3.51)*
IL-6 (ng/l) 88 3.15 (0.35e25.40) 88 3.30 (0.32e13.33) 88 2.80 (0.98e23.94)*x
IL-8 (ng/l) 88 7.61 (3.57e63.23) 88 6.82 (1.70e59.30) 88 6.21 (1.63e65.10)*x
IL-10 (ng/l) 88 1.12 (0.18e10.78) 88 0.91 (0.09e6.45)y 88 0.97 (0.10e4.55)x
TNF-a (ng/l) 88 5.47 (0.00e39.50) 88 6.17 (0.47e69.53)* 88 5.51 (1.26e53.48)
*Signiﬁcantly different from previous time point, p<0.05.
yp<0.001.
zSigniﬁcantly different from 0 h, p<0.05.
xp<0.001.
CRP, C reactive protein; FeNO, fractional exhaled nitric oxide.
Table 3 Selected lung function variables pre- and post-shift (0 and 8 h) in cement production workers, in non-smoking workers and in those without
doctor-diagnosed asthma or allergy
Parameter
Pre-shift (n[91),
mean (SD)
Post-shift (n[91),
mean (SD)
Cross-shift change
All workers (n[91),
mean (95% CI)
No allergy/asthma (n[70),
mean (95% CI)
Non-smokers (n[56),
mean (95% CI)
FVC (litres) 5.02 (0.91) 4.99 (0.97)  0.032 ( 0.066 to 0.0016)  0.041 ( 0.080 to 0.0023)*  0.050 ( 0.086 to 0.015)*
FEV1 (litres) 3.92 (0.81) 3.88 (0.81)  0.037 ( 0.072 to 0.0017)*  0.046 ( 0.086 to 0.0063)*  0.042 ( 0.075 to 0.009)*
FEV6 (litres)z 4.98 (0.93) 4.95 (0.97)  0.034 ( 0.070 to 0.0088)  0.046 ( 0.087 to 0.0049)*  0.053 ( 0.090 to 0.017)*
FEV1/FVC 78.1 (7.39) 78.0 (7.06)  0.15 ( 0.69 to 0.37)  0.20 ( 0.79 to 0.40)  0.034 ( 0.58 to 0.51)
PEF (l/s) 9.68 (1.69) 9.73 (1.82) 0.056 ( 0084 to 0.20) 0.053 ( 0.11 to 0.21)  0.0064 ( 0.19 to 0.18)
FEF25e75% (l/s) 3.39 (1.31) 3.22 (1.30)  0.17 ( 0.26 to 0.081)y  0.18 ( 0.28 to 0.070)y  0.15 ( 0.24 to 0.057)*
DLCO (mmol/min/kPa) 10.7 (2.1) 10.5 (2.0)  0.17 ( 0.32 to 0.023)*  0.052 ( 0.11 to 0.23)  0.25 ( 0.46 to 0.04)*
KCO (mmol/min/kPa/l) 1.57 (0.26) 1.55 (0.26)  0.02 ( 0.044 to 0.010)*  0.0041 ( 0.027 to 0.019)  0.026 ( 0.056 to 0.0035)
VA (litres) 6.85 (1.06) 6.85 (1.10) 0.0037 ( 0.061 to 0.069) 0.020 ( 0.058 to 0.098)  0.015 ( 0.10 to 0.072)
*Signiﬁcantly changed from before work shift, p<0.05.
yp<0.001.
zn¼89.
DLCO, carbon dioxide diffusion capacity; FEF, forced mid-expiratory ﬂow rate; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; KCO, carbon monoxide transfer per unit effective
alveolar volume; PEF, peak expiratory ﬂow; VA, alveolar volume.
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Workplacedifferences in ﬁbrinogen and hsCRP could indicate an effect on
blood coagulation among the workers. This ﬁnding could be
induced by workplace exposure or perhaps more likely is a result
of diurnal variation. Still, ﬁbrinogen levels show low biological
variability and the highest values in healthy, non-exposed
subjects are recorded in the late morning.
29 However, there was
no change in the level of D-dimer and the observed difference in
ﬁbrinogen is small. Hence, the observed increase in ﬁbrinogen
levels should be interpreted with caution.
We observed an increase in TNF-a and a decrease in IL-10
across the shift. The diurnal rhythmicity of the pro-inﬂamma-
tory cytokine TNF-a shows production peaks in the early
morning with a subsequent fall during the day,
30 whereas the
anti-inﬂammatory cytokine IL-10 peaks during daytime.
31 It is
not clear if our ﬁnding of an inverse pattern represents an
inﬂammatory response or if it is only a marker of exposure. The
ﬁnding agrees with results from studies of cytokine levels in
bronchial epithelial cells after exposure to cigarette smoke.
32 33
However, the changes are small and because no associations
with exposure were detected, it remains unclear if this ﬁnding
represents a true response.
Our data show that levels of the pro-inﬂammatory cytokines
IL-1b, IL-6 and IL-8 decreased during the observation period.
These ﬁndings, together with the FeNO results, are probably
indicative of no or low inﬂammatory activity. A decrease in
cytokine levels could also possibly occur if the workers had
higher levels of physical activity during the work shift than
during the preceding period of rest, as shown in studies of
healthy, non-exposed subjects.
34 35 However, it is noted that the
analysis of FeNO and inﬂammatory markers in our study is
based on the examination of effects at three different time
points only and it seems possible that other or additional time
points (eg, 4 h and 24 h) could have revealed other patterns of
response and made interpretation of these ﬁndings easier.
The changes in lung function indices and inﬂammatory
markers across the shift were similar in those without doctor-
diagnosed allergy or asthma as compared to the whole group of
workers. In non-smokers the changes in spirometric indices were
slightly stronger than in the whole group and the changes in
inﬂammatory markers were similar. These ﬁndings indicate that
the observed effects probably cannot be explained by allergy or
smoking alone. However, a decrease in the DLCO level of 0.60
(95% CI 0.29 to 0.91) mmol/min/kPa among those with allergy
or asthma was demonstrated, while there was no change among
those without these conditions. This could possibly indicate
that the changes in gas diffusion could be inﬂuenced by subjects
with hyper-responsive airways.
The personal sampling of aerosol concentration allows corre-
lation and linear regression analyses with exposure as a contin-
uous variable. Surprisingly, no correlations were observed
between exposure and cross-shift changes in the outcome vari-
ables. This was also the case when those using respirators and
those not were analysed separately. The respirable aerosol level
among the exposed workers in this study was well below the
Norwegian OEL (respirable aerosol, 5 mg/m
3), as was the
thoracic fraction. In addition, the exposure measurements
showed that the particle size of the aerosols in the measured
periods for both plants was mostly inhalable and therefore will
deposit in the upper respiratory system. Thus, other descriptors
of exposure such as the chemical composition of the aerosol at
different locations of the plant and peak exposures could be of
importance and should be considered for inclusion in further
studies. Furthermore, regression analysis showed that in the
workers with the highest levels of exposure, the pre-shift level of
ﬁbrinogen was associated with exposure, indicating that
previous exposure could also be of importance.
It is possible that individuals susceptible to adverse effects
from cement aerosols had left the cement industry, leaving only
robust subjects in the workforce to be included in the study. If
this were the case, we would have underestimated the inﬂam-
matory effects of exposure. However, because workers are used
as their own controls in this study, selection bias is probably less
important.
36 To reduce bias related to the collection of data, all
lung function tests were performed by one researcher. Standard
instructions were followed for spirometry, lung diffusion and
FeNO and the blood samples were analysed by individuals
blinded to exposure information.
Confounders that may not be controlled adequately or
adjusted for in the analysis could include unknown respiratory
irritants outside the workplace, especially in the period before
the ﬁrst health measurements were performed. It is also
possible that a greater cross-shift change in lung function,
FeNO, or in levels of inﬂammatory markers would have
occurred if the period of non-exposure before baseline had been
extended.
We observed a higher prevalence of smokers among the non-
participants than among the included subjects. This is not
considered to be a limitation of the study because it is likely that
existing tobacco smoke-related inﬂammatory effects among
these workers would have made detection of effects from the
cement production aerosol difﬁcult, resulting in an underesti-
mation rather than in an overestimation of effects.
It is not clear whether the cross-shift changes in lung function
indices and inﬂammatory markers as observed in this study
represent an early stage of inﬂammation leading to respiratory
disease or whether they represent an appropriate immune
response without clinical consequences. However, until follow-
up studies are completed and interpreted in relation to these
questions, we recommend a reduction in exposure for workers
with the highest exposure levels and that spirometric surveil-
lance is carried out at regular intervals.
In conclusion, we observed small but signiﬁcant cross-shift
reductions in FEV1, FEF25e75%,D L CO and FeNO levels corre-
sponding with increased numbers of leucocytes, elevated levels
of ﬁbrinogen and TNF-a and decreased levels of IL-10 in low
level-exposed cement production workers. Because the correla-
tions with exposure were weak and while the long-term
consequences of these acute changes in lung function indices and
inﬂammatory mediators are unknown, the hypothesis that low-
grade cement aerosol exposure causes airway disease should be
tested in a follow-up study.
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